JP2013510870A5 - - Google Patents

Download PDF

Info

Publication number
JP2013510870A5
JP2013510870A5 JP2012538997A JP2012538997A JP2013510870A5 JP 2013510870 A5 JP2013510870 A5 JP 2013510870A5 JP 2012538997 A JP2012538997 A JP 2012538997A JP 2012538997 A JP2012538997 A JP 2012538997A JP 2013510870 A5 JP2013510870 A5 JP 2013510870A5
Authority
JP
Japan
Prior art keywords
methyl
pharmaceutically acceptable
acceptable salt
fluoro
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012538997A
Other languages
English (en)
Japanese (ja)
Other versions
JP5723381B2 (ja
JP2013510870A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/056449 external-priority patent/WO2011060217A1/en
Publication of JP2013510870A publication Critical patent/JP2013510870A/ja
Publication of JP2013510870A5 publication Critical patent/JP2013510870A5/ja
Application granted granted Critical
Publication of JP5723381B2 publication Critical patent/JP5723381B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012538997A 2009-11-16 2010-11-12 Orl−1受容体アンタゴニストとしてのスピロピペリジン化合物 Active JP5723381B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09382245 2009-11-16
EP09382245.0 2009-11-16
US29862810P 2010-01-27 2010-01-27
US61/298,628 2010-01-27
PCT/US2010/056449 WO2011060217A1 (en) 2009-11-16 2010-11-12 Spiropiperidine compounds as orl-1 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2013510870A JP2013510870A (ja) 2013-03-28
JP2013510870A5 true JP2013510870A5 (https=) 2013-11-21
JP5723381B2 JP5723381B2 (ja) 2015-05-27

Family

ID=41800752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012538997A Active JP5723381B2 (ja) 2009-11-16 2010-11-12 Orl−1受容体アンタゴニストとしてのスピロピペリジン化合物

Country Status (18)

Country Link
US (1) US20120214784A1 (https=)
EP (1) EP2501704B1 (https=)
JP (1) JP5723381B2 (https=)
KR (1) KR101368130B1 (https=)
CN (1) CN102666550B (https=)
AU (1) AU2010319400B2 (https=)
BR (1) BR112012011710A2 (https=)
CA (1) CA2781041C (https=)
DK (1) DK2501704T3 (https=)
EA (1) EA020391B1 (https=)
ES (1) ES2436241T3 (https=)
HR (1) HRP20130969T1 (https=)
MX (1) MX2012005690A (https=)
PL (1) PL2501704T3 (https=)
PT (1) PT2501704E (https=)
RS (1) RS53017B (https=)
SI (1) SI2501704T1 (https=)
WO (1) WO2011060217A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106883246B (zh) * 2009-12-04 2020-05-29 桑诺维恩药品公司 多环化合物及其使用方法
TWI582096B (zh) * 2011-12-06 2017-05-11 美國禮來大藥廠 用於酒精依賴及濫用處理之4',5'-二氫螺[哌啶-4,7'-噻吩并[2,3-c]哌喃]化合物
TW201416370A (zh) 2012-07-31 2014-05-01 Lilly Co Eli 用於治療焦慮之orl-1受體拮抗劑
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
JO3638B1 (ar) * 2015-09-09 2020-08-27 Lilly Co Eli مركبات مفيدة في تثبيط ror - جاما- t
CA3032141A1 (en) 2016-07-29 2018-02-01 Vadim ALEXANDROV Compounds and compositions and uses thereof
UA125519C2 (uk) 2016-07-29 2022-04-13 Суновіон Фармасьютікалз Інк. Сполуки і композиції і їх застосування
KR20190037305A (ko) 2016-08-10 2019-04-05 바이엘 크롭사이언스 악티엔게젤샤프트 해충 방제제로서의 치환된 2-헤테로시클릴 이미다졸릴-카르복스아미드
IL268694B2 (en) 2017-02-16 2023-10-01 Sunovion Pharmaceuticals Inc Treatment of schizophrenia
DK3589637T3 (da) * 2017-03-02 2021-06-14 Lilly Co Eli Forbindelser, der er anvendelige til inhibering af ROR-GAMMA-T
PL3589638T3 (pl) 2017-03-02 2021-09-27 Eli Lilly And Company Związki użyteczne do hamowania ror-gamma-t
BR112020001433A2 (pt) 2017-08-02 2020-07-28 Sunovion Pharmaceuticals Inc. compostos de isocromano e usos dos mesmos
EA202091945A1 (ru) 2018-02-16 2021-01-18 Суновион Фармасьютикалз Инк. Соли, кристаллические формы и способы их получения
TWI848031B (zh) 2018-12-17 2024-07-11 美商維泰克斯製藥公司 Apol1抑制劑及其使用方法
MX2021010880A (es) 2019-03-14 2022-01-18 Sunovion Pharmaceuticals Inc Sales de un compuesto de isocromanilo y formas cristalinas, procesos de preparacion, usos terapeuticos y composiciones farmaceuticas de las mismas.
EP3766879A1 (en) 2019-07-19 2021-01-20 Basf Se Pesticidal pyrazole derivatives
CN115734785A (zh) 2020-04-14 2023-03-03 桑诺维恩药品公司 (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症
WO2021252863A1 (en) 2020-06-12 2021-12-16 Vertex Pharmaceuticals Incorporated Solid forms of apol1 inhibitor and using the same
IL300298B2 (en) 2020-08-26 2025-06-01 Vertex Pharma Inhibitors of apol1 and methods of using same
CN119343353A (zh) * 2022-02-08 2025-01-21 弗特克斯药品有限公司 作为APOL1抑制剂的2-甲基-4',5'-二氢螺[哌啶-4,7'-噻吩并[2,3-c]吡喃]衍生物和其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003235912A1 (en) 2002-05-10 2003-11-11 Taisho Pharmaceutical Co., Ltd. Spiro-ring compound
WO2005016913A1 (en) 2003-08-19 2005-02-24 Pfizer Japan, Inc. Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders
DE10360792A1 (de) * 2003-12-23 2005-07-28 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
CA2563164A1 (en) * 2004-03-29 2005-10-06 Pfizer Inc. Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists
DE102004039382A1 (de) * 2004-08-13 2006-02-23 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
US7655670B2 (en) * 2005-06-02 2010-02-02 Janssen Pharmaceutica N.V. 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators

Similar Documents

Publication Publication Date Title
JP2013510870A5 (https=)
JP2013510859A5 (https=)
HRP20130969T1 (hr) Spojevi spiropiperidona kao antagonisti receptora orl-1
JP6424219B2 (ja) 複素芳香環−ベンジル−アミド−サイクルコアを含むオートタキシン阻害剤
JP6572294B2 (ja) 殺菌・殺カビ性アゾ環式アミド
CA2699933C (en) Fungicidal mixtures
HRP20130967T1 (hr) Spojevi spiropiperidona kao antagonisti receptora orl-1
ES2568882T3 (es) Derivado de azol
ME01462B (me) Vinilindazolilna jedinjenja"
JP2016535772A5 (https=)
WO2013042138A3 (en) Process for preparation of triazole antifungal drug, its intermediates and polymorphs thereof
JP2016519156A5 (https=)
JP2017039755A5 (https=)
RU2016102647A (ru) Ингибиторы бромодомена
JP2013532709A5 (https=)
JP2008513500A5 (https=)
CL2014000384A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-alquinil/alquenil-etil)-1h-(1,2,4) triazol sustituidos; proceso para preparar dichos compuestos; composiciones agroquímicas.
PE20190345A1 (es) Combinaciones de compuestos activos
AR072201A1 (es) 2-arilaminoquinazolinas para el tratamiento de enfermedades proliferativas
RU2010147925A (ru) 1-арил-3-аминоалкоксипиразолы как сигма-лиганды, усиливающие обезболивающее действие опиоидов и ослабляющие зависимость от них
JP2014501732A5 (https=)
RU2017107506A (ru) Конденсированные 11-членные соединения и содержащие их сельскохозяйственные/садоводческие фунгициды
RU2015148766A (ru) Комбинации лигандов альфа-2 адренорецептора и сигма рецептора
RU2019123319A (ru) Пиразолопиримидины и способы их применения
CN109790158A (zh) 作为jak抑制剂杂环化合物,该化合物的盐类及其治疗用途